GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLAW) » Definitions » Beginning Cash Position

Estrella Immunopharma (Estrella Immunopharma) Beginning Cash Position : $9.05 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Beginning Cash Position?

Estrella Immunopharma's Beginning Cash Position for the quarter that ended in Mar. 2024 was $9.05 Mil.

Estrella Immunopharma's quarterly Beginning Cash Position declined from Sep. 2023 ($22.53 Mil) to Dec. 2023 ($15.24 Mil) and declined from Dec. 2023 ($15.24 Mil) to Mar. 2024 ($9.05 Mil).

Estrella Immunopharma Beginning Cash Position Historical Data

The historical data trend for Estrella Immunopharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Beginning Cash Position Chart

Estrella Immunopharma Annual Data
Trend Jun21
Beginning Cash Position
-

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.99 2.88 22.53 15.24 9.05

Estrella Immunopharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Estrella Immunopharma Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Estrella Immunopharma (Estrella Immunopharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLAW) » Definitions » Beginning Cash Position
Comparable Companies
EYEN FGEN ADCT VANI IPA AFMD KNTE KZR SABS ELTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ESLA:USA
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Website
https://www.estrellabio.com
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines